rs114499642
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.
|
29907492 |
2018 |
rs74412765
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.
|
29907492 |
2018 |
rs76872642
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association analyses identified loci associated with attention/vigilance (rs830786 within HNF4G), verbal memory (rs67017972 near NDUFS4), and reasoning/problem solving (rs76872642 within HDAC9).
|
29907492 |
2018 |
rs2142694
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151).
|
27046643 |
2016 |
rs9771228
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151).
|
27046643 |
2016 |
rs17108533
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
|
21107309 |
2011 |
rs17126180
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
|
21107309 |
2011 |
rs17689437
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
|
21107309 |
2011 |
rs17706989
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
|
21107309 |
2011 |
rs2286720
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
|
21107309 |
2011 |
rs2833556
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
|
21107309 |
2011 |
rs3753242
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
|
21107309 |
2011 |
rs4611189
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
|
21107309 |
2011 |